annual CAPEX:
$7.30M-$14.27M(-66.16%)Summary
- As of today (July 4, 2025), VIR annual capital expenditures is $7.30 million, with the most recent change of -$14.27 million (-66.16%) on December 31, 2024.
- During the last 3 years, VIR annual CAPEX has fallen by -$14.52 million (-66.54%).
- VIR annual CAPEX is now -89.26% below its all-time high of $68.01 million, reached on December 31, 2022.
Performance
VIR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$1.63M-$778.00K(-32.32%)Summary
- As of today (July 4, 2025), VIR quarterly capital expenditures is $1.63 million, with the most recent change of -$778.00 thousand (-32.32%) on March 31, 2025.
- Over the past year, VIR quarterly CAPEX has dropped by -$243.00 thousand (-12.98%).
- VIR quarterly CAPEX is now -92.09% below its all-time high of $20.60 million, reached on June 30, 2022.
Performance
VIR quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$7.06M-$243.00K(-3.33%)Summary
- As of today (July 4, 2025), VIR TTM capital expenditures is $7.06 million, with the most recent change of -$243.00 thousand (-3.33%) on March 31, 2025.
- Over the past year, VIR TTM CAPEX has dropped by -$9.52 million (-57.43%).
- VIR TTM CAPEX is now -89.70% below its all-time high of $68.50 million, reached on September 30, 2022.
Performance
VIR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VIR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.2% | -13.0% | -57.4% |
| 3 y3 years | -66.5% | -89.7% | -80.9% |
| 5 y5 years | -18.3% | +25.1% | +29.4% |
VIR CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.3% | at low | -92.1% | +144.6% | -89.7% | +9.8% |
| 5 y | 5-year | -89.3% | +11.5% | -92.1% | +144.6% | -89.7% | +29.4% |
| alltime | all time | -89.3% | +166.3% | -92.1% | +144.6% | -89.7% | +103.0% |
VIR CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.63M(-32.3%) | $7.06M(-3.3%) |
| Dec 2024 | $7.30M(-66.2%) | $2.41M(+2.2%) | $7.30M(+13.6%) |
| Sep 2024 | - | $2.36M(+253.8%) | $6.43M(-17.4%) |
| Jun 2024 | - | $666.00K(-64.4%) | $7.79M(-53.0%) |
| Mar 2024 | - | $1.87M(+22.0%) | $16.58M(-23.2%) |
| Dec 2023 | $21.57M(-68.3%) | $1.53M(-58.7%) | $21.57M(-33.8%) |
| Sep 2023 | - | $3.71M(-60.7%) | $32.61M(-31.9%) |
| Jun 2023 | - | $9.46M(+37.7%) | $47.89M(-18.9%) |
| Mar 2023 | - | $6.87M(-45.4%) | $59.03M(-13.2%) |
| Dec 2022 | $68.01M(+211.7%) | $12.57M(-33.8%) | $68.01M(-0.7%) |
| Sep 2022 | - | $18.99M(-7.8%) | $68.50M(+23.4%) |
| Jun 2022 | - | $20.60M(+30.0%) | $55.51M(+50.1%) |
| Mar 2022 | - | $15.84M(+21.2%) | $36.99M(+69.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $21.82M(+233.1%) | $13.07M(+117.6%) | $21.82M(+95.1%) |
| Sep 2021 | - | $6.01M(+189.2%) | $11.18M(+68.2%) |
| Jun 2021 | - | $2.08M(+211.4%) | $6.65M(+12.4%) |
| Mar 2021 | - | $667.00K(-72.6%) | $5.91M(-9.7%) |
| Dec 2020 | $6.55M(-26.7%) | $2.43M(+64.9%) | $6.55M(+15.5%) |
| Sep 2020 | - | $1.47M(+9.8%) | $5.67M(+4.0%) |
| Jun 2020 | - | $1.34M(+3.1%) | $5.45M(-19.4%) |
| Mar 2020 | - | $1.30M(-16.1%) | $6.77M(-24.3%) |
| Dec 2019 | $8.94M(+9.1%) | $1.55M(+23.5%) | $8.94M(+21.0%) |
| Sep 2019 | - | $1.26M(-52.7%) | $7.39M(+20.5%) |
| Jun 2019 | - | $2.65M(-23.6%) | $6.13M(+76.4%) |
| Mar 2019 | - | $3.48M | $3.48M |
| Dec 2018 | $8.19M(+198.8%) | - | - |
| Dec 2017 | $2.74M | - | - |
FAQ
- What is Vir Biotechnology annual capital expenditures?
- What is the all time high annual CAPEX for Vir Biotechnology?
- What is Vir Biotechnology annual CAPEX year-on-year change?
- What is Vir Biotechnology quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vir Biotechnology?
- What is Vir Biotechnology quarterly CAPEX year-on-year change?
- What is Vir Biotechnology TTM capital expenditures?
- What is the all time high TTM CAPEX for Vir Biotechnology?
- What is Vir Biotechnology TTM CAPEX year-on-year change?
What is Vir Biotechnology annual capital expenditures?
The current annual CAPEX of VIR is $7.30M
What is the all time high annual CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high annual capital expenditures is $68.01M
What is Vir Biotechnology annual CAPEX year-on-year change?
Over the past year, VIR annual capital expenditures has changed by -$14.27M (-66.16%)
What is Vir Biotechnology quarterly capital expenditures?
The current quarterly CAPEX of VIR is $1.63M
What is the all time high quarterly CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high quarterly capital expenditures is $20.60M
What is Vir Biotechnology quarterly CAPEX year-on-year change?
Over the past year, VIR quarterly capital expenditures has changed by -$243.00K (-12.98%)
What is Vir Biotechnology TTM capital expenditures?
The current TTM CAPEX of VIR is $7.06M
What is the all time high TTM CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high TTM capital expenditures is $68.50M
What is Vir Biotechnology TTM CAPEX year-on-year change?
Over the past year, VIR TTM capital expenditures has changed by -$9.52M (-57.43%)